We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 490

Supreme Court revives FTC reverse payment challenge; says agreements can violate antitrust laws

  • Williams Mullen
  • -
  • USA
  • -
  • June 18 2013

The U.S. Supreme Court has issued one of its more anticipated rulings of this term in a decision that aims squarely at the intersection of antitrust

Supreme Court rules that “pay for delay” generic drug patent settlements are not shielded from antitrust liability

  • Baker & Hostetler LLP
  • -
  • USA
  • -
  • June 18 2013

The Supreme Court has held that the antitrust laws may forbid patent settlements that delay the market entry of generic drugs in return for large

Supreme Court says ‘reverse payment’ generic drug settlements are subject to rule of reason antitrust review

  • Debevoise & Plimpton LLP
  • -
  • USA
  • -
  • June 18 2013

On June 17, 2013, the U.S. Supreme Court issued a much anticipated ruling in Federal Trade Commission v. Actavis, Inc. regarding the validity of

Supreme Court rules on reverse payment settlements in Federal Trade Commission v Actavis Inc

  • Fenwick & West LLP
  • -
  • USA
  • -
  • June 17 2013

Today, the U.S. Supreme Court held in Federal Trade Commission v. Actavis, Inc. that so-called "reverse payment" settlement agreements should be

FTC: dentists not shielded from teeth-whitening competition

  • Baker & Hostetler LLP
  • -
  • USA
  • -
  • June 13 2013

In a ruling that may impact how professionals attempt to limit competition from alternative providers, the North Carolina State Board of Dental

FTC again confirms that antitrust law encourages ACO formation

  • Baker & Hostetler LLP
  • -
  • USA
  • -
  • June 13 2013

Once again, the staff of the Federal Trade Commission (FTC) has rebutted calls by physician groups that state legislation is needed to allow

ACOs and antitrust are aligned and compatible, says Commissioner Brill

  • McDermott Will & Emery
  • -
  • USA
  • -
  • June 13 2013

FTC Commissioner Julie Brill addressed attendees at the 2013 National Summit on Provider Market Power on June 11. The focus of her remarks were on

Fourth Circuit & FTC: state dental board subject to federal antitrust laws in teeth-whitening case

  • Mintz Levin Cohn Ferris Glovsky and Popeo PC
  • -
  • USA
  • -
  • June 13 2013

The health care industry is familiar with the FTC's enforcement presence for anticompetitive business practices in health care markets. But in a case

State action exemption narrowed by Fourth Circuit ruling

  • Jones Day
  • -
  • USA
  • -
  • June 13 2013

The Fourth Circuit Court of Appeals has ruled that North Carolina's Dental Board cannot ban non-dentists from offering teeth-whitening service

Antitrust law encourages accountable care organizations (“ACOs”) formation

  • Baker & Hostetler LLP
  • -
  • USA
  • -
  • June 12 2013

Once again, the staff of the Federal Trade Commission ("FTC") has rebutted claims by physician groups that state legislation is needed to allow